Patents by Inventor Brett Ewald

Brett Ewald has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180169271
    Abstract: Disclosed are replication-competent oncolytic adenoviruses, comprising chimeric human/mouse CD40 ligands. The oncolytic adenoviruses may be replication competent. The chimeric human/mouse CD40 ligand may be MEM40. Also disclosed are methods comprising administering a replication competent oncolytic adenovirus armed with at least one chimeric human/mouse CD40 ligand, for example MEM40, to a patient suffering from a cancer.
    Type: Application
    Filed: December 19, 2017
    Publication date: June 21, 2018
    Applicants: Memgen, LLC, DNAtrix
    Inventors: Mark J. Cantwell, Winnie M. Chan, Brett Ewald, Joan M. Robbins